NASDAQ : CPIX
Cumberland Pharmaceuticals Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 4.69 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 70.27M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cumberland Pharmaceuticals Inc. (CPIX) reported revenue of 44.30M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 40.18M | 40.40M | 36.54M | 37.51M | 40.68M | 35.05M |
| Other Revenue | 4.13M | 4.13M | 1.33M | 2.04M | 1.33M | 939.78K |
| Revenue | 44.30M | 44.52M | 37.87M | 39.55M | 42.01M | 35.99M |
| Cost of Revenue | 6.67M | 6.67M | 6.59M | 6.07M | 9.12M | 8.81M |
| Gross Profit | 37.64M | 37.85M | 31.28M | 33.49M | 32.89M | 27.17M |
| Selling, General & Admin | 31.06M | 31.05M | 28.15M | 29.10M | 26.84M | 24.80M |
| Research & Development | 5.58M | 5.57M | 4.82M | 5.83M | 6.69M | 5.68M |
| Amortization of Goodwill & Intangibles | 4.04M | 4.03M | 4.75M | 4.76M | 5.07M | 4.37M |
| Operating Expenses | 40.68M | 40.65M | 37.71M | 39.70M | 38.60M | 34.85M |
| Operating Income | -3.04M | -2.79M | -6.43M | -6.21M | -5.70M | -7.68M |
| Interest Expense | -491.92K | -495.99K | -605.51K | -667.86K | -586.00K | -98.03K |
| Interest & Investment Income | 362.46K | 476.75K | 334.44K | 286.85K | 98.41K | 26.08K |
| Earnings From Equity Investments | -13.22K | -13.22K | ||||
| Other Non Operating Income (Expenses) | 3.30M | |||||
| EBT Excluding Unusual Items | -3.19M | -2.82M | -6.70M | -3.29M | -6.19M | -7.75M |
| Asset Writedown | -3.34M | |||||
| Other Unusual Items | 2.19M | |||||
| Pretax Income | -3.19M | -2.82M | -6.47M | -6.28M | -5.58M | -5.56M |
| Income Tax Expense | 36.66K | 40.26K | -22.67K | 45.77K | 68.85K | 34.89K |
| Earnings From Continuing Operations | -3.22M | -2.86M | -6.44M | -6.33M | -5.65M | -5.60M |
| Earnings From Discontinued Operations | -7.72M | 1.99M | ||||
| Net Income to Company | -10.94M | -2.86M | -6.44M | -6.33M | -5.65M | -3.60M |
| Minority Interest in Earnings | 20.70K | 28.58K | -36.05K | 51.45K | 79.80K | 95.21K |
| Net Income | -10.92M | -2.84M | -6.48M | -6.28M | -5.57M | -3.51M |
| Net Income to Common | -10.92M | -2.84M | -6.48M | -6.28M | -5.57M | -3.51M |
| Shares Outstanding (Basic) | 14.86M | 14.85M | 14.06M | 14.30M | 14.56M | 14.90M |
| Shares Outstanding (Diluted) | 14.86M | 14.85M | 14.06M | 14.30M | 14.56M | 14.90M |
| EPS (Basic) | -0.73 | -0.19 | -0.46 | -0.44 | -0.38 | -0.24 |
| EPS (Diluted) | -0.74 | -0.19 | -0.46 | -0.44 | -0.38 | -0.24 |
| Free Cash Flow | 683.90K | 4.83M | -678.65K | 5.81M | 8.35M | 6.24M |
| Free Cash Flow Per Share | 0.05 | 0.33 | -0.05 | 0.41 | 0.57 | 0.42 |
| Gross Margin | 84.95% | 85.02% | 82.61% | 84.66% | 78.30% | 75.51% |
| Operating Margin | -6.87% | -6.27% | -16.99% | -15.70% | -13.58% | -21.34% |
| Profit Margin | -24.64% | -6.37% | -17.11% | -15.88% | -13.26% | -9.75% |
| Free Cash Flow Margin | 1.54% | 10.86% | -1.79% | 14.70% | 19.88% | 17.34% |
| EBITDA | 1.10M | 1.35M | -1.53M | -1.27M | -376.82K | -3.07M |
| EBITDA Margin | 2.48% | 3.04% | -4.04% | -3.22% | -0.90% | -8.53% |
| D&A For EBITDA | 4.14M | 4.15M | 4.90M | 4.94M | 5.33M | 4.61M |
| EBIT | -3.04M | -2.79M | -6.43M | -6.21M | -5.70M | -7.68M |
| EBIT Margin | -6.87% | -6.27% | -16.99% | -15.70% | -13.58% | -21.34% |
| Revenue as Reported | 44.52M | 44.52M | 37.87M | 39.55M | 42.01M | 35.99M |
| Advertising Expenses | 2.73M | 2.99M | 2.90M | 2.93M | 1.93M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.86M | 11.44M | 17.96M | 18.32M | 19.76M | 27.04M |
| Cash & Short-Term Investments | 3.86M | 11.44M | 17.96M | 18.32M | 19.76M | 27.04M |
| Receivables | 13.42M | 16.94M | 11.70M | 9.76M | 13.16M | 6.88M |
| Inventory | 29.93K | 6.23M | 4.00M | 4.61M | 9.86M | 8.43M |
| Prepaid Expenses | 675.99K | 2.45M | 2.79M | 3.03M | 3.08M | 3.34M |
| Other Current Assets | 15.65M | |||||
| Total Current Assets | 33.64M | 37.06M | 36.45M | 35.71M | 45.87M | 45.69M |
| Property, Plant & Equipment | 7.53M | 8.61M | 6.45M | 7.04M | 5.50M | 1.47M |
| Long-Term Investments | 3.99M | |||||
| Goodwill | 914.00K | 914.00K | 914.00K | 914.00K | 882.00K | |
| Other Intangible Assets | 43.80K | 14.03M | 17.97M | 22.61M | 30.59M | 23.95M |
| Other Long-Term Assets | 21.66M | 12.23M | 13.79M | 15.50M | 10.05M | 12.47M |
| Total Assets | 62.88M | 76.82M | 75.58M | 81.78M | 92.93M | 84.46M |
| Accounts Payable | 19.55M | 18.57M | 13.91M | 14.04M | 10.82M | 9.64M |
| Accrued Expenses | 7.52M | 10.03M | 9.74M | 9.16M | 10.80M | 5.04M |
| Short-Term Debt | 5.10M | |||||
| Current Portion of Leases | 503.02K | 467.77K | 356.51K | 348.09K | 172.91K | 969.68K |
| Other Current Liabilities | 7.62M | 7.68M | 2.51M | 4.43M | 6.79M | 3.63M |
| Total Current Liabilities | 35.19M | 36.74M | 31.62M | 27.98M | 28.58M | 19.28M |
| Long-Term Debt | 5.24M | 10.18M | 12.78M | 16.20M | 15.00M | |
| Long-Term Leases | 4.21M | 4.47M | 4.94M | 5.30M | 4.59M | 90.02K |
| Other Long-Term Liabilities | 6.37M | 5.82M | 6.30M | 6.45M | 7.59M | 7.49M |
| Total Liabilities | 45.77M | 52.28M | 53.04M | 52.52M | 56.95M | 41.86M |
| Common Stock | 51.81M | 51.68M | 46.82M | 47.09M | 47.47M | 48.45M |
| Retained Earnings | -34.37M | -26.80M | -23.97M | -17.49M | -11.21M | -5.64M |
| Total Common Equity | 17.44M | 24.88M | 22.85M | 29.60M | 36.27M | 42.81M |
| Minority Interest | -331.56K | -336.10K | -307.52K | -343.57K | -292.13K | -212.33K |
| Shareholders' Equity | 17.11M | 24.54M | 22.55M | 29.26M | 35.97M | 42.60M |
| Total Liabilities & Equity | 62.88M | 76.82M | 75.58M | 81.78M | 92.93M | 84.46M |
| Total Debt | 4.71M | 10.18M | 20.57M | 18.43M | 20.96M | 16.06M |
| Net Cash (Debt) | -851.78K | 1.26M | -2.61M | -106.86K | -1.20M | 10.98M |
| Net Cash Per Share | -0.06 | 0.09 | -0.19 | -0.01 | -0.08 | 0.74 |
| Filing Date Shares Outstanding | 14.98M | 14.96M | 13.97M | 14.18M | 14.40M | 14.84M |
| Total Common Shares Outstanding | 14.98M | 14.96M | 13.95M | 14.12M | 14.37M | 14.74M |
| Working Capital | -1.55M | 315.35K | 4.83M | 7.73M | 17.29M | 26.41M |
| Book Value Per Share | 1.16 | 1.66 | 1.64 | 2.10 | 2.52 | 2.90 |
| Tangible Book Value | 17.39M | 9.94M | 3.97M | 6.08M | 4.76M | 17.98M |
| Tangible Book Value Per Share | 1.16 | 0.66 | 0.28 | 0.43 | 0.33 | 1.22 |
| Machinery | 1.93M | 1.84M | 1.81M | 1.58M | 2.81M | |
| Leasehold Improvements | 841.66K | 825.07K | 800.97K | 787.75K | 1.42M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -10.92M | -2.84M | -6.48M | -6.28M | -5.57M | -3.51M |
| Depreciation & Amortization | 5.28M | 5.29M | 6.04M | 5.77M | 5.33M | 4.61M |
| Asset Writedown & Restructuring Costs | 3.34M | |||||
| Loss (Gain) From Sale of Investments | 13.22K | 13.22K | ||||
| Stock-Based Compensation | 438.13K | 408.32K | 301.89K | 365.04K | 447.50K | 741.87K |
| Other Operating Activities | -219.62K | -101.76K | -1.77M | -1.74M | -2.19M | -5.67M |
| Change in Accounts Receivable | -3.10M | -5.24M | -1.94M | 3.40M | -6.12M | 5.50M |
| Change in Inventory | 2.14M | 2.24M | 2.41M | -23.14K | 911.08K | 4.82M |
| Change in Accounts Payable | 9.44M | 6.71M | -991.36K | 3.72M | 14.54M | -757.59K |
| Change in Other Net Operating Assets | -935.27K | -1.55M | 1.82M | -2.47M | 1.11M | -1.38M |
| Operating Cash Flow | 745.97K | 4.93M | -612.19K | 6.09M | 8.45M | 6.34M |
| Capital Expenditures | -62.07K | -97.90K | -66.46K | -281.27K | -102.15K | -103.53K |
| Cash Acquisitions | -13.50M | |||||
| Sale (Purchase) of Intangibles | -81.48K | -84.40K | -113.25K | -171.78K | -1.97M | -250.93K |
| Investment in Securities | -6.23M | -4.48M | ||||
| Other Investing Activities | 623.20K | -47.00K | 237.56K | 347.36K | 1.90M | -147.43K |
| Investing Cash Flow | -5.75M | -4.71M | 57.84K | -105.69K | -13.67M | -501.89K |
| Long-Term Debt Issued | 38.49M | 31.48M | 52.90M | 59.00M | ||
| Long-Term Debt Repaid | -10.04M | -36.00M | -34.89M | -51.70M | -59.00M | |
| Net Debt Issued (Repaid) | -5.24M | -10.04M | 2.49M | -3.42M | 1.20M | |
| Issuance of Common Stock | 5.27M | |||||
| Repurchase of Common Stock | -71.44K | -263.48K | -579.05K | -740.53K | -1.05M | -1.39M |
| Other Financing Activities | -1.91M | -1.71M | -1.72M | -3.27M | -2.21M | -2.17M |
| Financing Cash Flow | -7.22M | -6.75M | 196.90K | -7.42M | -2.06M | -3.55M |
| Net Cash Flow | -12.22M | -6.52M | -357.44K | -1.44M | -7.28M | 2.29M |
| Free Cash Flow | 683.90K | 4.83M | -678.65K | 5.81M | 8.35M | 6.24M |
| Free Cash Flow Margin | 1.54% | 10.86% | -1.79% | 14.70% | 19.88% | 17.34% |
| Free Cash Flow Per Share | 0.05 | 0.33 | -0.05 | 0.41 | 0.57 | 0.42 |
| Levered Free Cash Flow | -191.17K | 6.44M | -797.34K | 9.33M | 2.40M | 361.33K |
| Unlevered Free Cash Flow | 116.28K | 6.75M | -418.90K | 9.75M | 2.77M | 422.60K |
| Cash Income Tax Paid | -3.52K | 15.00K | 108.82K | 3.30K | -327.00 | |
| Change in Working Capital | 7.54M | 2.16M | 1.29M | 4.63M | 10.44M | 8.18M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 66.08M | 59.53M | 33.28M | 26.70M | 32.54M | 68.90M |
| Enterprise Value | 66.93M | 54.25M | 36.99M | 26.51M | 30.66M | 59.21M |
| Last Close Price | 4.69 | 3.09 | 1.84 | 1.39 | 1.74 | 3.62 |
| Forward PE | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | |
| PS Ratio | 1.59 | 1.34 | 0.88 | 0.68 | 0.78 | 1.92 |
| PB Ratio | 4.03 | 2.42 | 1.48 | 0.91 | 0.91 | 1.62 |
| P/TBV Ratio | 4.04 | 5.99 | 8.39 | 4.39 | 6.83 | 3.83 |
| P/FCF Ratio | 102.75 | 12.31 | 4.59 | 3.90 | 11.04 | |
| P/OCF Ratio | 94.20 | 12.07 | 4.38 | 3.85 | 10.86 | |
| PEG Ratio | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | |
| EV/Sales Ratio | 1.61 | 1.22 | 0.98 | 0.67 | 0.73 | 1.65 |
| EV/EBITDA Ratio | 64.85 | 40.09 | ||||
| EV/FCF Ratio | 104.00 | 11.22 | 4.56 | 3.67 | 9.49 | |
| Debt / Equity Ratio | 0.28 | 0.41 | 0.91 | 0.63 | 0.58 | 0.38 |
| Debt / EBITDA Ratio | 1.42 | 2.83 | 50.39 | 32.10 | 15.97 | |
| Debt / FCF Ratio | 6.89 | 2.11 | 3.17 | 2.51 | 2.57 | |
| Net Debt / Equity Ratio | 0.05 | -0.05 | 0.12 | 0.00 | 0.03 | -0.26 |
| Net Debt / EBITDA Ratio | 0.78 | -0.93 | -1.71 | -0.08 | -3.19 | 3.58 |
| Net Debt / FCF Ratio | 1.25 | -0.26 | -3.84 | 0.02 | 0.14 | -1.76 |
| Asset Turnover | 0.68 | 0.58 | 0.48 | 0.45 | 0.47 | 0.40 |
| Inventory Turnover | 4.10 | 1.30 | 1.53 | 0.84 | 1.00 | 0.92 |
| Quick Ratio | 0.49 | 0.77 | 0.94 | 1.00 | 1.15 | 1.76 |
| Current Ratio | 0.96 | 1.01 | 1.15 | 1.28 | 1.60 | 2.37 |
| Return on Equity (ROE) | -14.39% | -12.17% | -24.88% | -19.41% | -14.38% | -12.51% |
| Return on Assets (ROA) | -2.91% | -2.29% | -5.11% | -4.44% | -4.02% | -5.30% |
| Return on Invested Capital (ROIC) | -15.88% | -11.53% | -23.60% | -18.67% | -16.59% | -21.68% |
| Return on Capital Employed (ROCE) | -11.00% | -7.00% | -14.60% | -11.50% | -8.90% | -11.80% |
| Earnings Yield | -16.77% | -4.76% | -19.47% | -23.51% | -17.12% | -5.09% |
| FCF Yield | 0.97% | 8.12% | -2.04% | 21.77% | 25.66% | 9.05% |
| Buyback Yield / Dilution | -2.64% | -5.65% | 1.67% | 1.82% | 2.29% | 1.70% |